雷贝拉唑钠原料药中有关物质的HPLC 法测定

宋冬梅,刘 路,江文明,杨永健*

PDF(5319 KB)
主办:上海医药工业研究院
   中国药学会
   中国化学制药工业协会
ISSN 1001-8255   CN 31-1243/R   ZYGZEA
PDF(5319 KB)
中国医药工业杂志 ›› 2015, Vol. 46 ›› Issue (09) : 1013-1016. DOI: 10.16522/j.cnki.cjph.2015.09.019
药品分析与质控 Analysis & Quality Control

雷贝拉唑钠原料药中有关物质的HPLC 法测定

作者信息 +

Determination of Related Substances in Rabeprazole Sodium Bulk Drug by HPLC

Author information +
History +

摘要

建立了高效液相色谱法测定雷贝拉唑钠原料药中的7 个有关物质。采用C18 色谱柱,以15 mmol/L 磷酸氢二钠溶液( 用磷酸调至pH 6.0) ∶乙腈(60 ∶ 40) 为流动相,检测波长290 nm。雷贝拉唑钠及6 个有关物质均在0.04 ~ 10 μg/ml范围内线性关系良好,另一有关物质2-[(4- 甲氧基-3- 甲基吡啶-2- 基) 甲亚磺酰基]-1H- 苯并咪唑的线性范围为0.04 ~5 μg/ml。7 个有关物质回收率为101.34%~ 107.90%,RSD 为1.00%~ 6.35%。

Abstract

An HPLC method was established for the determination of the related substances in rabeprazole sodium bulk drug. A C18 column was used, with the mobile phase of 15 mmol/L disodium hydrogen phosphate solution (adjusted to pH 6.0 with phosphoric acid)∶acetonitrile (60∶40), at the detection wavelength of 290 nm. The calibration curves of rabeprazole sodium and six related substances were linear in the ranges of 0.04 - 10 μg/ml, while it was linear in the range of 0.04 - 5 μg/ml for 2-[[(4-methoxy-3-methylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole. The recoveries for seven related substances were 101.34% - 107.90%, with RSDs of 1.00% - 6.35%.

关键词

雷贝拉唑钠 / 有关物质 / 高效液相色谱 / 测定

Key words

rabeprazole sodium / related substance / HPLC / determination

引用本文

导出引用
宋冬梅,刘 路,江文明,杨永健*. 雷贝拉唑钠原料药中有关物质的HPLC 法测定. 中国医药工业杂志. 2015, 46(09): 1013-1016 https://doi.org/10.16522/j.cnki.cjph.2015.09.019
SONG Dongmei, LIU Lu, JIANG Wenming, YANG Yongjian*. Determination of Related Substances in Rabeprazole Sodium Bulk Drug by HPLC. Chinese Journal of Pharmaceuticals. 2015, 46(09): 1013-1016 https://doi.org/10.16522/j.cnki.cjph.2015.09.019

参考文献

[1] Reddy GM, Bhaskar BV, Reddy PP, et al. Identification and characterization of potential impurities of rabeprazole sodium [J]. J Pharm Biomed Anal, 2007, 43(4): 1262-1269.

[2] Vasu Dev R, Sai Uday Kiran G, Venkata Subbaiah B, et al. Identification of degradation products in stressed tablets of rabeprazole sodium by HPLC-hyphenated techniques [J].

Magn Reson Chem, 2009, 47(5): 443-448.

[3] Rao PS, Ray UK, Gupta PB, et al. Identification, isolation and characterization of new impurity in rabeprazole sodium [J]. J Pharm Biomed Anal, 2010, 52(4): 620-624.

[4] Garcia CV, Nudelman NS, Steppe M, et al. Structural elucidation of rabeprazole sodium photodegradation products [J]. J Pharm Biomed Anal, 2008, 46(1): 88-93.

[5] Miura M, Tada H, Satoh S, et al. Determination of rabeprazole enantiomers and their metabolites by high-performance liquid chromatography with solid-phase extraction [J]. J

Pharm Biomed Anal, 2006, 41(2): 565-570.

[6] 孙国祥, 丁 楠, 王 真, 等. HPLC-DAD-MS 鉴定注射用雷贝拉唑钠杂质及其特征谱研究[J]. 沈阳药科大学学报,2011, 28(6): 433-437.

[7] 陈 敖, 王智慧. 雷贝拉唑的合成[J]. 精细与专用化学品,2010, 18(2): 28-29.

[8] 刘 路, 江文明, 任美婷, 等. 雷贝拉唑钠原料药中一未知有关物质的结构解析[ J] . 中国医药工业杂志, 2013,44(12): 1268-1271.

基金

上海市科学技术委员会项目(11DZ1920907)

PDF(5319 KB)

160

Accesses

0

Citation

Detail

段落导航
相关文章

/